Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8 T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 539, doi. 10.1007/s00262-015-1655-y
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 5
Results: 11
1
2
Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 573, doi. 10.1007/s00262-015-1657-9
- By:
- Publication type:
- Article
3
The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 551, doi. 10.1007/s00262-015-1662-z
- By:
- Publication type:
- Article
4
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 563, doi. 10.1007/s00262-015-1663-y
- By:
- Publication type:
- Article
5
Broadening the repertoire of melanoma-associated T-cell epitopes.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 609, doi. 10.1007/s00262-015-1664-x
- By:
- Publication type:
- Article
6
NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 599, doi. 10.1007/s00262-015-1665-9
- By:
- Publication type:
- Article
7
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 635, doi. 10.1007/s00262-015-1666-8
- By:
- Publication type:
- Article
8
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8 T cells in NOD/SCID/IL2Rg(null) mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 645, doi. 10.1007/s00262-015-1668-6
- By:
- Publication type:
- Article
9
Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 621, doi. 10.1007/s00262-015-1669-5
- By:
- Publication type:
- Article
10
Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 531, doi. 10.1007/s00262-015-1684-6
- By:
- Publication type:
- Article
11
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 5, p. 585, doi. 10.1007/s00262-014-1649-1
- By:
- Publication type:
- Article